Bio B2B 〉 Selective Search Results
Your Selection Setting ：Botanic Drug；
Selective Search Results :
Biotech Companies 7 record(s)；
PhytoHealth Corporation, a member of Maywufa Biopharma Group of companies, was incorporated in 1998 as a new drug development company with focus on research & development, clinical trial, manufacturing, marketing & sales of novel botanical drugs and chemically synthesized drugs.PhytoHealth successfully held its IPO in 2002, being the first new drug development company to be listed
Oneness Biotech Co., Ltd.
We began in 2008 as a government-approved biopharmaceutical company devoted to New Drug Development. In 2011, Oneness became a listed company on the over-the-counter market in Taiwan under the approval of the Securities and Futures Bureau.Today, our vision, our mission and our strategy identify who we are as a company at Oneness.Our VisionOur goal is to become a leading international biotech
Panion & BF Biotech Inc.
IntroductionEstablished in 1976, Panion & BF Biotech (PBF) is a company specialized in the manufacturing of pharmaceutical products With its diligent effort to seek business transformation, upgrade and expansion over the past years, PBF is now a well-established international biopharmaceutical company specialized in diversified operations, including new drug development, drug manufacturing, cosmeceutical/nutraceuticals
Microbio Co., Ltd.
MICROBIO, which was founded in 2000, has experienced over a decade of growth and remains dedicated to “novel therapeutics development and human lifestyle improvement”. MICROBIO Group's approach to innovative and responsible drug development has led to two successful drug approvals by the Taiwanese Food and Drug Administration (TFDA). In addition to drug development, we have expanded
Sinphar Pharmaceutical Co., Ltd.
Upholding its philosophy, “public's health is Sinphar's ideal” Sinphar Group has accompanied the public for almost 40 years. All these time, the company has always embraced its focus on “life, health, and technology” in developing therapeutic drugs, health care foods, and medical beauty products to provide the public with the best service for protecting their health
SynCore Biotechnology Co., Ltd.
SynCore Biotechnology Co., Ltd (“SynCore”) is a biopharmaceutial company focusing on creating values of new drug by R&D and integration of technology resources. SynCore was established in 2008 and cofounded by Sinphar Group and National Health Research Institute (NHRI). SynCore inherited Sinphar's experiences which have been accumulated for more than 30 years in R&D, manufacturing
Vita Genomics, Inc.
The Leading Pharmacogenomics Company in Asia PacificVita Genomics, founded in March 2001, has established its headquarters and main facility in Taipei, Taiwan since January 2002. The mission of Vita Genomics is to study and understand what affects the Asian population in order to better diagnose, treat, and eventually cure diseases. Currently, in order to provide clinical and omics services to clinical